This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Aviva Systems Biology
product type :
antibody
product name :
Goat Anti-BIF-1 / SH3GLB1 Antibody (OAEB01689)
catalog :
OAEB01689
quantity :
100 ug
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, rat, dogs, zebrafish
application :
western blot
product information
sku :
OAEB01689
product type :
Polyclonal Antibody
category :
Polyclonal
name :
Goat Anti-BIF-1 / SH3GLB1 Antibody (OAEB01689)
size :
100 ug
gene symbol :
SH3GLB1
alias symbols :
Bif-1, endophilin B1, SH3-domain GRB2-like endophilin B1, SH3GLB1
protein accession num :
NP_057093.1
swissprot id :
Q9Y371
species reactivity :
Dog, Horse, Human, Pig, Rabbit, Rat, Zebrafish
product format :
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
peptide sequence :
C-QKGKVPITYLELLN
reconstitution and storage :
Aliquot and store at -20C. Minimize freezing and thawing.
host :
Goat
application :
WB
homology :
Dog: 92%; Horse: 92%; Human: 100%; Pig: 92%; Rabbit: 100%; Rat: 100%; Zebrafish: 100%
clonality :
Polyclonal
purity :
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
application info :
Peptide ELISA: antibody detection limit dilution 1:32000.Western Blot: Approx 38kDa band observed in lysates of Human T cell line Jurkat and in Human Lung and Placenta (calculated MW of 40.8kDa according to NP_057093.1). Recommended concentration: 0.3-1.0 ug/ml. A minor band of unknown identity was also consistently observed at 50kDa in Jurkat and Placenta. This band was successfully blocked by incubation with the immunising peptide.
drywet surcharge :
Wet Ice
storage temperature :
-20C
company information
Aviva Systems Biology
7700 Ronson Road, Ste 100, San Diego, CA 92111
info@avivasysbio.com
http://www.avivasysbio.com1-858-552-6979
headquarters: United States
questions and comments